Zentalis Pharmaceuticals Inc (ZNTL)
11.71
+0.60
(+5.40%)
USD |
NASDAQ |
May 03, 16:00
11.71
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Net Income (Quarterly): -60.92M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -60.92M |
| September 30, 2023 | -55.53M |
| June 30, 2023 | -112.53M |
| March 31, 2023 | -63.22M |
| December 31, 2022 | -54.97M |
| September 30, 2022 | -54.40M |
| June 30, 2022 | -68.36M |
| March 31, 2022 | -59.08M |
| December 31, 2021 | -50.06M |
| September 30, 2021 | -4.191M |
| Date | Value |
|---|---|
| June 30, 2021 | -54.57M |
| March 31, 2021 | -49.90M |
| December 31, 2020 | -40.30M |
| September 30, 2020 | -34.56M |
| June 30, 2020 | -26.86M |
| March 31, 2020 | -16.13M |
| December 31, 2019 | -14.51M |
| September 30, 2019 | -12.34M |
| June 30, 2019 | -10.47M |
| March 31, 2019 | -8.343M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-112.53M
Minimum
Jun 2023
-4.191M
Maximum
Sep 2021
-44.36M
Average
-50.06M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
| Revolution Medicines Inc | -161.54M |
| Day One Biopharmaceuticals Inc | -54.51M |
| Perspective Therapeutics Inc | -24.68M |
| Electromed Inc | 1.674M |
| Xtant Medical Holdings Inc | -4.303M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 67.92M |
| EPS Diluted (Quarterly) | -0.83 |
| Enterprise Value | 348.13M |
| Earnings Yield | -38.77% |